Shanx Medtech BV raised €15 million (US$17.5 million) in a seed funding round for its in vitro diagnostic platform for ultra-rapid antimicrobial susceptibility testing. The financing came from a range ...

Researchers have devised a method for investigating how effective antibiotics are against different bacterial strains.

Antimicrobial resistance (AMR) remains a major global healthcare challenge, undermining the effectiveness of treatments for common infections and threatening modern medical advances. Improved ...

NEW YORK, NY, UNITED STATES, September 9, 2024 / EINPresswire.com / -- CD BioSciences announced the launch of its innovative biofilm antimicrobial susceptibility testing services designed to provide ...

Antimicrobial resistance (AMR) is a mounting global challenge driven by the misuse of drugs and the rapid adaptability of microbes. As resistant bacteria spread across health systems, agriculture and ...

Detailed price information for Fendx Technologies Inc. (FNDX-CN) from The Globe and Mail including charting and trades.

Growing number of hospitals across major markets. Increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods.

This Collection supports and amplifies research related to SDG 3, SDG 6 and SDG 14. Antimicrobial resistance (AMR) is a global public health threat. AMR is associated with millions of deaths worldwide ...

Drugs that act against bacteria are mainly assessed based on how well they inhibit bacterial growth under laboratory ...

Investigators working at the Jiangxi Science & Technology Normal University, China, have reported the development of novel ruthenium polypyridine antibiotics with demonstrably promising in vitro and ...

The latest update is out from Biosenta Inc ( (TSE:ZRO)). Biosenta Inc. has entered into a Field Test and Research Agreement with Livespace Homes to evaluate the real-world performance of its ...